nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—PTPN1—nipple—breast cancer	0.0195	0.088	CbGeAlD
Tiludronate—PTPN1—embryo—breast cancer	0.0161	0.0726	CbGeAlD
Tiludronate—ATP6V1A—mammary gland—breast cancer	0.0142	0.0637	CbGeAlD
Tiludronate—PTPN1—endometrium—breast cancer	0.0118	0.0531	CbGeAlD
Tiludronate—ATP6V1A—nipple—breast cancer	0.0117	0.0527	CbGeAlD
Tiludronate—PTPN1—uterus—breast cancer	0.0109	0.049	CbGeAlD
Tiludronate—PTPN1—pituitary gland—breast cancer	0.0107	0.0481	CbGeAlD
Tiludronate—PTPN1—adipose tissue—breast cancer	0.0106	0.0479	CbGeAlD
Tiludronate—PTPN1—female reproductive system—breast cancer	0.00977	0.044	CbGeAlD
Tiludronate—ATP6V1A—embryo—breast cancer	0.00966	0.0435	CbGeAlD
Tiludronate—PTPN1—adrenal gland—breast cancer	0.00954	0.043	CbGeAlD
Tiludronate—PTPN1—female gonad—breast cancer	0.00889	0.0401	CbGeAlD
Tiludronate—PTPN1—endocrine gland—breast cancer	0.00827	0.0373	CbGeAlD
Tiludronate—ATP6V1A—skin of body—breast cancer	0.0075	0.0338	CbGeAlD
Tiludronate—ATP6V1A—endometrium—breast cancer	0.00707	0.0318	CbGeAlD
Tiludronate—ATP6V1A—uterus—breast cancer	0.00651	0.0293	CbGeAlD
Tiludronate—ATP6V1A—pituitary gland—breast cancer	0.0064	0.0288	CbGeAlD
Tiludronate—ATP6V1A—adipose tissue—breast cancer	0.00637	0.0287	CbGeAlD
Tiludronate—ATP6V1A—female reproductive system—breast cancer	0.00585	0.0264	CbGeAlD
Tiludronate—PTPN1—lymph node—breast cancer	0.00572	0.0258	CbGeAlD
Tiludronate—ATP6V1A—adrenal gland—breast cancer	0.00571	0.0257	CbGeAlD
Tiludronate—ATP6V1A—bone marrow—breast cancer	0.00553	0.0249	CbGeAlD
Tiludronate—ATP6V1A—female gonad—breast cancer	0.00533	0.024	CbGeAlD
Tiludronate—ATP6V1A—endocrine gland—breast cancer	0.00495	0.0223	CbGeAlD
Tiludronate—ATP6V1A—lymph node—breast cancer	0.00342	0.0154	CbGeAlD
Tiludronate—Gastrointestinal pain—Anastrozole—breast cancer	0.00122	0.00337	CcSEcCtD
Tiludronate—Headache—Fulvestrant—breast cancer	0.00121	0.00335	CcSEcCtD
Tiludronate—Pain—Raloxifene—breast cancer	0.00121	0.00335	CcSEcCtD
Tiludronate—Back pain—Tamoxifen—breast cancer	0.00121	0.00334	CcSEcCtD
Tiludronate—Asthenia—Exemestane—breast cancer	0.0012	0.00333	CcSEcCtD
Tiludronate—Headache—Toremifene—breast cancer	0.00119	0.0033	CcSEcCtD
Tiludronate—Abdominal pain—Anastrozole—breast cancer	0.00118	0.00326	CcSEcCtD
Tiludronate—Abdominal pain—Letrozole—breast cancer	0.00118	0.00326	CcSEcCtD
Tiludronate—Gastrointestinal pain—Idarubicin—breast cancer	0.00115	0.0032	CcSEcCtD
Tiludronate—Gastrointestinal pain—Raloxifene—breast cancer	0.00115	0.0032	CcSEcCtD
Tiludronate—Vertigo—Vinblastine—breast cancer	0.00115	0.0032	CcSEcCtD
Tiludronate—Back pain—Goserelin—breast cancer	0.00115	0.00319	CcSEcCtD
Tiludronate—Diarrhoea—Exemestane—breast cancer	0.00114	0.00317	CcSEcCtD
Tiludronate—Nausea—Fulvestrant—breast cancer	0.00114	0.00317	CcSEcCtD
Tiludronate—Asthenia—Ixabepilone—breast cancer	0.00113	0.00314	CcSEcCtD
Tiludronate—Nausea—Toremifene—breast cancer	0.00113	0.00313	CcSEcCtD
Tiludronate—Abdominal pain—Raloxifene—breast cancer	0.00112	0.00309	CcSEcCtD
Tiludronate—Abdominal pain—Idarubicin—breast cancer	0.00112	0.00309	CcSEcCtD
Tiludronate—Dizziness—Exemestane—breast cancer	0.00111	0.00307	CcSEcCtD
Tiludronate—Diarrhoea—Ixabepilone—breast cancer	0.00108	0.00299	CcSEcCtD
Tiludronate—Asthenia—Letrozole—breast cancer	0.00107	0.00296	CcSEcCtD
Tiludronate—Asthenia—Anastrozole—breast cancer	0.00107	0.00296	CcSEcCtD
Tiludronate—Myalgia—Tamoxifen—breast cancer	0.00106	0.00294	CcSEcCtD
Tiludronate—Arthralgia—Tamoxifen—breast cancer	0.00106	0.00294	CcSEcCtD
Tiludronate—Headache—Exemestane—breast cancer	0.00105	0.00291	CcSEcCtD
Tiludronate—Dizziness—Ixabepilone—breast cancer	0.00104	0.00289	CcSEcCtD
Tiludronate—Myalgia—Melphalan—breast cancer	0.00104	0.00288	CcSEcCtD
Tiludronate—Back pain—Vinorelbine—breast cancer	0.00103	0.00286	CcSEcCtD
Tiludronate—Diarrhoea—Letrozole—breast cancer	0.00102	0.00282	CcSEcCtD
Tiludronate—Diarrhoea—Anastrozole—breast cancer	0.00102	0.00282	CcSEcCtD
Tiludronate—Myalgia—Goserelin—breast cancer	0.00101	0.00281	CcSEcCtD
Tiludronate—Arthralgia—Goserelin—breast cancer	0.00101	0.00281	CcSEcCtD
Tiludronate—Rhinitis—Mitoxantrone—breast cancer	0.00101	0.00281	CcSEcCtD
Tiludronate—Rhinitis—Irinotecan—breast cancer	0.00101	0.00281	CcSEcCtD
Tiludronate—Dyspepsia—Chlorambucil—breast cancer	0.00101	0.00279	CcSEcCtD
Tiludronate—Nausea—Exemestane—breast cancer	0.000994	0.00276	CcSEcCtD
Tiludronate—Headache—Ixabepilone—breast cancer	0.000989	0.00274	CcSEcCtD
Tiludronate—Rhinitis—Gemcitabine—breast cancer	0.000987	0.00274	CcSEcCtD
Tiludronate—Back pain—Thiotepa—breast cancer	0.000985	0.00273	CcSEcCtD
Tiludronate—Dizziness—Anastrozole—breast cancer	0.000983	0.00273	CcSEcCtD
Tiludronate—Dizziness—Letrozole—breast cancer	0.000983	0.00273	CcSEcCtD
Tiludronate—Bone pain—Epirubicin—breast cancer	0.000979	0.00271	CcSEcCtD
Tiludronate—Pain—Chlorambucil—breast cancer	0.000977	0.00271	CcSEcCtD
Tiludronate—Rhinitis—Fluorouracil—breast cancer	0.00097	0.00269	CcSEcCtD
Tiludronate—Diarrhoea—Idarubicin—breast cancer	0.000966	0.00268	CcSEcCtD
Tiludronate—Diarrhoea—Raloxifene—breast cancer	0.000966	0.00268	CcSEcCtD
Tiludronate—Vertigo—Vinorelbine—breast cancer	0.000958	0.00266	CcSEcCtD
Tiludronate—Nausea—Ixabepilone—breast cancer	0.000938	0.0026	CcSEcCtD
Tiludronate—Gastrointestinal pain—Chlorambucil—breast cancer	0.000935	0.00259	CcSEcCtD
Tiludronate—Dizziness—Raloxifene—breast cancer	0.000933	0.00259	CcSEcCtD
Tiludronate—Headache—Letrozole—breast cancer	0.000931	0.00258	CcSEcCtD
Tiludronate—Headache—Anastrozole—breast cancer	0.000931	0.00258	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Tamoxifen—breast cancer	0.000927	0.00257	CcSEcCtD
Tiludronate—Influenza like illness—Epirubicin—breast cancer	0.000911	0.00253	CcSEcCtD
Tiludronate—Myalgia—Vinorelbine—breast cancer	0.000908	0.00252	CcSEcCtD
Tiludronate—Arthralgia—Vinorelbine—breast cancer	0.000908	0.00252	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Melphalan—breast cancer	0.000908	0.00252	CcSEcCtD
Tiludronate—Bone pain—Doxorubicin—breast cancer	0.000906	0.00251	CcSEcCtD
Tiludronate—Abdominal pain—Chlorambucil—breast cancer	0.000904	0.0025	CcSEcCtD
Tiludronate—Pain—Vinblastine—breast cancer	0.000896	0.00248	CcSEcCtD
Tiludronate—Dyspepsia—Tamoxifen—breast cancer	0.000896	0.00248	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Goserelin—breast cancer	0.000885	0.00245	CcSEcCtD
Tiludronate—Headache—Idarubicin—breast cancer	0.000884	0.00245	CcSEcCtD
Tiludronate—Headache—Raloxifene—breast cancer	0.000884	0.00245	CcSEcCtD
Tiludronate—Nausea—Letrozole—breast cancer	0.000883	0.00245	CcSEcCtD
Tiludronate—Nausea—Anastrozole—breast cancer	0.000883	0.00245	CcSEcCtD
Tiludronate—Dyspepsia—Melphalan—breast cancer	0.000877	0.00243	CcSEcCtD
Tiludronate—Pain—Tamoxifen—breast cancer	0.00087	0.00241	CcSEcCtD
Tiludronate—Arthralgia—Thiotepa—breast cancer	0.000867	0.0024	CcSEcCtD
Tiludronate—Myalgia—Thiotepa—breast cancer	0.000867	0.0024	CcSEcCtD
Tiludronate—Gastrointestinal pain—Vinblastine—breast cancer	0.000856	0.00237	CcSEcCtD
Tiludronate—Dyspepsia—Goserelin—breast cancer	0.000855	0.00237	CcSEcCtD
Tiludronate—Pain—Melphalan—breast cancer	0.000852	0.00236	CcSEcCtD
Tiludronate—Back pain—Irinotecan—breast cancer	0.000851	0.00236	CcSEcCtD
Tiludronate—Back pain—Mitoxantrone—breast cancer	0.000851	0.00236	CcSEcCtD
Tiludronate—Influenza like illness—Doxorubicin—breast cancer	0.000843	0.00234	CcSEcCtD
Tiludronate—Nausea—Idarubicin—breast cancer	0.000838	0.00232	CcSEcCtD
Tiludronate—Nausea—Raloxifene—breast cancer	0.000838	0.00232	CcSEcCtD
Tiludronate—Gastrointestinal pain—Tamoxifen—breast cancer	0.000832	0.00231	CcSEcCtD
Tiludronate—Pain—Goserelin—breast cancer	0.000831	0.0023	CcSEcCtD
Tiludronate—Back pain—Gemcitabine—breast cancer	0.000829	0.0023	CcSEcCtD
Tiludronate—Abdominal pain—Vinblastine—breast cancer	0.000828	0.0023	CcSEcCtD
Tiludronate—Rhinitis—Paclitaxel—breast cancer	0.000826	0.00229	CcSEcCtD
Tiludronate—Asthenia—Chlorambucil—breast cancer	0.00082	0.00227	CcSEcCtD
Tiludronate—Abdominal pain—Tamoxifen—breast cancer	0.000804	0.00223	CcSEcCtD
Tiludronate—Gastrointestinal pain—Goserelin—breast cancer	0.000795	0.0022	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Vinorelbine—breast cancer	0.000793	0.0022	CcSEcCtD
Tiludronate—Vertigo—Irinotecan—breast cancer	0.00079	0.00219	CcSEcCtD
Tiludronate—Diarrhoea—Chlorambucil—breast cancer	0.000782	0.00217	CcSEcCtD
Tiludronate—Abdominal pain—Goserelin—breast cancer	0.000768	0.00213	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Thiotepa—breast cancer	0.000757	0.0021	CcSEcCtD
Tiludronate—Asthenia—Vinblastine—breast cancer	0.000751	0.00208	CcSEcCtD
Tiludronate—Myalgia—Mitoxantrone—breast cancer	0.000749	0.00208	CcSEcCtD
Tiludronate—Arthralgia—Mitoxantrone—breast cancer	0.000749	0.00208	CcSEcCtD
Tiludronate—Pain—Vinorelbine—breast cancer	0.000744	0.00206	CcSEcCtD
Tiludronate—Dyspepsia—Thiotepa—breast cancer	0.000732	0.00203	CcSEcCtD
Tiludronate—Asthenia—Tamoxifen—breast cancer	0.00073	0.00202	CcSEcCtD
Tiludronate—Myalgia—Gemcitabine—breast cancer	0.000729	0.00202	CcSEcCtD
Tiludronate—Arthralgia—Gemcitabine—breast cancer	0.000729	0.00202	CcSEcCtD
Tiludronate—Myalgia—Fluorouracil—breast cancer	0.000717	0.00199	CcSEcCtD
Tiludronate—Diarrhoea—Vinblastine—breast cancer	0.000717	0.00199	CcSEcCtD
Tiludronate—Asthenia—Melphalan—breast cancer	0.000715	0.00198	CcSEcCtD
Tiludronate—Gastrointestinal pain—Vinorelbine—breast cancer	0.000712	0.00197	CcSEcCtD
Tiludronate—Pain—Thiotepa—breast cancer	0.000711	0.00197	CcSEcCtD
Tiludronate—Rhinitis—Docetaxel—breast cancer	0.0007	0.00194	CcSEcCtD
Tiludronate—Asthenia—Goserelin—breast cancer	0.000697	0.00193	CcSEcCtD
Tiludronate—Diarrhoea—Tamoxifen—breast cancer	0.000696	0.00193	CcSEcCtD
Tiludronate—Back pain—Paclitaxel—breast cancer	0.000694	0.00192	CcSEcCtD
Tiludronate—Dizziness—Vinblastine—breast cancer	0.000693	0.00192	CcSEcCtD
Tiludronate—Abdominal pain—Vinorelbine—breast cancer	0.000688	0.00191	CcSEcCtD
Tiludronate—Diarrhoea—Melphalan—breast cancer	0.000682	0.00189	CcSEcCtD
Tiludronate—Gastrointestinal pain—Thiotepa—breast cancer	0.00068	0.00188	CcSEcCtD
Tiludronate—Nausea—Chlorambucil—breast cancer	0.000679	0.00188	CcSEcCtD
Tiludronate—Rhinitis—Capecitabine—breast cancer	0.000678	0.00188	CcSEcCtD
Tiludronate—Dizziness—Tamoxifen—breast cancer	0.000673	0.00187	CcSEcCtD
Tiludronate—Diarrhoea—Goserelin—breast cancer	0.000665	0.00184	CcSEcCtD
Tiludronate—Abdominal pain—Thiotepa—breast cancer	0.000657	0.00182	CcSEcCtD
Tiludronate—Headache—Vinblastine—breast cancer	0.000656	0.00182	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.000654	0.00181	CcSEcCtD
Tiludronate—Vertigo—Paclitaxel—breast cancer	0.000645	0.00179	CcSEcCtD
Tiludronate—Dizziness—Goserelin—breast cancer	0.000643	0.00178	CcSEcCtD
Tiludronate—Headache—Tamoxifen—breast cancer	0.000637	0.00177	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000637	0.00177	CcSEcCtD
Tiludronate—Dyspepsia—Mitoxantrone—breast cancer	0.000632	0.00175	CcSEcCtD
Tiludronate—Dyspepsia—Irinotecan—breast cancer	0.000632	0.00175	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000626	0.00174	CcSEcCtD
Tiludronate—Asthenia—Vinorelbine—breast cancer	0.000625	0.00173	CcSEcCtD
Tiludronate—Nausea—Vinblastine—breast cancer	0.000622	0.00172	CcSEcCtD
Tiludronate—Pain—Irinotecan—breast cancer	0.000614	0.0017	CcSEcCtD
Tiludronate—Pain—Mitoxantrone—breast cancer	0.000614	0.0017	CcSEcCtD
Tiludronate—Myalgia—Paclitaxel—breast cancer	0.000611	0.00169	CcSEcCtD
Tiludronate—Arthralgia—Paclitaxel—breast cancer	0.000611	0.00169	CcSEcCtD
Tiludronate—Headache—Goserelin—breast cancer	0.000609	0.00169	CcSEcCtD
Tiludronate—Dyspepsia—Fluorouracil—breast cancer	0.000605	0.00168	CcSEcCtD
Tiludronate—Nausea—Tamoxifen—breast cancer	0.000604	0.00168	CcSEcCtD
Tiludronate—Pain—Gemcitabine—breast cancer	0.000598	0.00166	CcSEcCtD
Tiludronate—Asthenia—Thiotepa—breast cancer	0.000596	0.00165	CcSEcCtD
Tiludronate—Diarrhoea—Vinorelbine—breast cancer	0.000596	0.00165	CcSEcCtD
Tiludronate—Nausea—Melphalan—breast cancer	0.000592	0.00164	CcSEcCtD
Tiludronate—Back pain—Docetaxel—breast cancer	0.000588	0.00163	CcSEcCtD
Tiludronate—Pain—Fluorouracil—breast cancer	0.000588	0.00163	CcSEcCtD
Tiludronate—Gastrointestinal pain—Irinotecan—breast cancer	0.000587	0.00163	CcSEcCtD
Tiludronate—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000587	0.00163	CcSEcCtD
Tiludronate—Nausea—Goserelin—breast cancer	0.000577	0.0016	CcSEcCtD
Tiludronate—Dizziness—Vinorelbine—breast cancer	0.000576	0.0016	CcSEcCtD
Tiludronate—Back pain—Capecitabine—breast cancer	0.000569	0.00158	CcSEcCtD
Tiludronate—Diarrhoea—Thiotepa—breast cancer	0.000569	0.00158	CcSEcCtD
Tiludronate—Abdominal pain—Mitoxantrone—breast cancer	0.000567	0.00157	CcSEcCtD
Tiludronate—Abdominal pain—Irinotecan—breast cancer	0.000567	0.00157	CcSEcCtD
Tiludronate—Dizziness—Thiotepa—breast cancer	0.00055	0.00152	CcSEcCtD
Tiludronate—Headache—Vinorelbine—breast cancer	0.000545	0.00151	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000533	0.00148	CcSEcCtD
Tiludronate—Vertigo—Capecitabine—breast cancer	0.000529	0.00147	CcSEcCtD
Tiludronate—Headache—Thiotepa—breast cancer	0.000521	0.00144	CcSEcCtD
Tiludronate—Arthralgia—Docetaxel—breast cancer	0.000518	0.00143	CcSEcCtD
Tiludronate—Myalgia—Docetaxel—breast cancer	0.000518	0.00143	CcSEcCtD
Tiludronate—Nausea—Vinorelbine—breast cancer	0.000517	0.00143	CcSEcCtD
Tiludronate—Dyspepsia—Paclitaxel—breast cancer	0.000515	0.00143	CcSEcCtD
Tiludronate—Asthenia—Mitoxantrone—breast cancer	0.000515	0.00143	CcSEcCtD
Tiludronate—Asthenia—Irinotecan—breast cancer	0.000515	0.00143	CcSEcCtD
Tiludronate—Asthenia—Gemcitabine—breast cancer	0.000502	0.00139	CcSEcCtD
Tiludronate—Arthralgia—Capecitabine—breast cancer	0.000501	0.00139	CcSEcCtD
Tiludronate—Myalgia—Capecitabine—breast cancer	0.000501	0.00139	CcSEcCtD
Tiludronate—Pain—Paclitaxel—breast cancer	0.000501	0.00139	CcSEcCtD
Tiludronate—Nausea—Thiotepa—breast cancer	0.000494	0.00137	CcSEcCtD
Tiludronate—Diarrhoea—Irinotecan—breast cancer	0.000491	0.00136	CcSEcCtD
Tiludronate—Diarrhoea—Mitoxantrone—breast cancer	0.000491	0.00136	CcSEcCtD
Tiludronate—Gastrointestinal pain—Paclitaxel—breast cancer	0.000479	0.00133	CcSEcCtD
Tiludronate—Diarrhoea—Gemcitabine—breast cancer	0.000478	0.00133	CcSEcCtD
Tiludronate—Dizziness—Irinotecan—breast cancer	0.000475	0.00132	CcSEcCtD
Tiludronate—Rhinitis—Epirubicin—breast cancer	0.000472	0.00131	CcSEcCtD
Tiludronate—Diarrhoea—Fluorouracil—breast cancer	0.00047	0.0013	CcSEcCtD
Tiludronate—Abdominal pain—Paclitaxel—breast cancer	0.000463	0.00128	CcSEcCtD
Tiludronate—Dizziness—Fluorouracil—breast cancer	0.000455	0.00126	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000452	0.00125	CcSEcCtD
Tiludronate—Headache—Irinotecan—breast cancer	0.00045	0.00125	CcSEcCtD
Tiludronate—Headache—Mitoxantrone—breast cancer	0.00045	0.00125	CcSEcCtD
Tiludronate—Headache—Gemcitabine—breast cancer	0.000438	0.00121	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000438	0.00121	CcSEcCtD
Tiludronate—Rhinitis—Doxorubicin—breast cancer	0.000437	0.00121	CcSEcCtD
Tiludronate—Dyspepsia—Docetaxel—breast cancer	0.000437	0.00121	CcSEcCtD
Tiludronate—Headache—Fluorouracil—breast cancer	0.000431	0.00119	CcSEcCtD
Tiludronate—Nausea—Mitoxantrone—breast cancer	0.000426	0.00118	CcSEcCtD
Tiludronate—Nausea—Irinotecan—breast cancer	0.000426	0.00118	CcSEcCtD
Tiludronate—Pain—Docetaxel—breast cancer	0.000424	0.00118	CcSEcCtD
Tiludronate—Back pain—Methotrexate—breast cancer	0.000424	0.00118	CcSEcCtD
Tiludronate—Dyspepsia—Capecitabine—breast cancer	0.000423	0.00117	CcSEcCtD
Tiludronate—Asthenia—Paclitaxel—breast cancer	0.00042	0.00116	CcSEcCtD
Tiludronate—Nausea—Gemcitabine—breast cancer	0.000415	0.00115	CcSEcCtD
Tiludronate—Pain—Capecitabine—breast cancer	0.000411	0.00114	CcSEcCtD
Tiludronate—Nausea—Fluorouracil—breast cancer	0.000408	0.00113	CcSEcCtD
Tiludronate—Gastrointestinal pain—Docetaxel—breast cancer	0.000406	0.00112	CcSEcCtD
Tiludronate—Diarrhoea—Paclitaxel—breast cancer	0.000401	0.00111	CcSEcCtD
Tiludronate—Back pain—Epirubicin—breast cancer	0.000397	0.0011	CcSEcCtD
Tiludronate—Vertigo—Methotrexate—breast cancer	0.000394	0.00109	CcSEcCtD
Tiludronate—Gastrointestinal pain—Capecitabine—breast cancer	0.000393	0.00109	CcSEcCtD
Tiludronate—Abdominal pain—Docetaxel—breast cancer	0.000392	0.00109	CcSEcCtD
Tiludronate—Dizziness—Paclitaxel—breast cancer	0.000387	0.00107	CcSEcCtD
Tiludronate—Abdominal pain—Capecitabine—breast cancer	0.00038	0.00105	CcSEcCtD
Tiludronate—Arthralgia—Methotrexate—breast cancer	0.000373	0.00103	CcSEcCtD
Tiludronate—Myalgia—Methotrexate—breast cancer	0.000373	0.00103	CcSEcCtD
Tiludronate—Vertigo—Epirubicin—breast cancer	0.000368	0.00102	CcSEcCtD
Tiludronate—Back pain—Doxorubicin—breast cancer	0.000367	0.00102	CcSEcCtD
Tiludronate—Headache—Paclitaxel—breast cancer	0.000367	0.00102	CcSEcCtD
Tiludronate—Asthenia—Docetaxel—breast cancer	0.000356	0.000987	CcSEcCtD
Tiludronate—Arthralgia—Epirubicin—breast cancer	0.000349	0.000968	CcSEcCtD
Tiludronate—Myalgia—Epirubicin—breast cancer	0.000349	0.000968	CcSEcCtD
Tiludronate—Nausea—Paclitaxel—breast cancer	0.000348	0.000964	CcSEcCtD
Tiludronate—Asthenia—Capecitabine—breast cancer	0.000345	0.000956	CcSEcCtD
Tiludronate—Vertigo—Doxorubicin—breast cancer	0.000341	0.000945	CcSEcCtD
Tiludronate—Diarrhoea—Docetaxel—breast cancer	0.00034	0.000941	CcSEcCtD
Tiludronate—Diarrhoea—Capecitabine—breast cancer	0.000329	0.000911	CcSEcCtD
Tiludronate—Dizziness—Docetaxel—breast cancer	0.000328	0.00091	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000326	0.000903	CcSEcCtD
Tiludronate—Myalgia—Doxorubicin—breast cancer	0.000323	0.000896	CcSEcCtD
Tiludronate—Arthralgia—Doxorubicin—breast cancer	0.000323	0.000896	CcSEcCtD
Tiludronate—Dizziness—Capecitabine—breast cancer	0.000318	0.000881	CcSEcCtD
Tiludronate—Dyspepsia—Methotrexate—breast cancer	0.000315	0.000873	CcSEcCtD
Tiludronate—Headache—Docetaxel—breast cancer	0.000311	0.000862	CcSEcCtD
Tiludronate—Pain—Methotrexate—breast cancer	0.000306	0.000848	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000305	0.000845	CcSEcCtD
Tiludronate—Headache—Capecitabine—breast cancer	0.000301	0.000834	CcSEcCtD
Tiludronate—Nausea—Docetaxel—breast cancer	0.000295	0.000817	CcSEcCtD
Tiludronate—Dyspepsia—Epirubicin—breast cancer	0.000295	0.000817	CcSEcCtD
Tiludronate—Gastrointestinal pain—Methotrexate—breast cancer	0.000292	0.000811	CcSEcCtD
Tiludronate—Pain—Epirubicin—breast cancer	0.000286	0.000793	CcSEcCtD
Tiludronate—Nausea—Capecitabine—breast cancer	0.000285	0.000791	CcSEcCtD
Tiludronate—Abdominal pain—Methotrexate—breast cancer	0.000283	0.000784	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000282	0.000782	CcSEcCtD
Tiludronate—Gastrointestinal pain—Epirubicin—breast cancer	0.000274	0.000759	CcSEcCtD
Tiludronate—Dyspepsia—Doxorubicin—breast cancer	0.000273	0.000756	CcSEcCtD
Tiludronate—Pain—Doxorubicin—breast cancer	0.000265	0.000734	CcSEcCtD
Tiludronate—Abdominal pain—Epirubicin—breast cancer	0.000265	0.000733	CcSEcCtD
Tiludronate—Asthenia—Methotrexate—breast cancer	0.000257	0.000711	CcSEcCtD
Tiludronate—Gastrointestinal pain—Doxorubicin—breast cancer	0.000253	0.000702	CcSEcCtD
Tiludronate—Abdominal pain—Doxorubicin—breast cancer	0.000245	0.000679	CcSEcCtD
Tiludronate—Diarrhoea—Methotrexate—breast cancer	0.000245	0.000678	CcSEcCtD
Tiludronate—Asthenia—Epirubicin—breast cancer	0.00024	0.000666	CcSEcCtD
Tiludronate—Dizziness—Methotrexate—breast cancer	0.000237	0.000656	CcSEcCtD
Tiludronate—Diarrhoea—Epirubicin—breast cancer	0.000229	0.000635	CcSEcCtD
Tiludronate—Headache—Methotrexate—breast cancer	0.000224	0.000621	CcSEcCtD
Tiludronate—Asthenia—Doxorubicin—breast cancer	0.000222	0.000616	CcSEcCtD
Tiludronate—Dizziness—Epirubicin—breast cancer	0.000221	0.000614	CcSEcCtD
Tiludronate—Nausea—Methotrexate—breast cancer	0.000212	0.000589	CcSEcCtD
Tiludronate—Diarrhoea—Doxorubicin—breast cancer	0.000212	0.000587	CcSEcCtD
Tiludronate—Headache—Epirubicin—breast cancer	0.00021	0.000581	CcSEcCtD
Tiludronate—Dizziness—Doxorubicin—breast cancer	0.000205	0.000568	CcSEcCtD
Tiludronate—Nausea—Epirubicin—breast cancer	0.000199	0.000551	CcSEcCtD
Tiludronate—Headache—Doxorubicin—breast cancer	0.000194	0.000538	CcSEcCtD
Tiludronate—Nausea—Doxorubicin—breast cancer	0.000184	0.00051	CcSEcCtD
Tiludronate—ATP6V1A—Disease—ERCC2—breast cancer	0.000134	0.00032	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RPS6—breast cancer	0.000133	0.000318	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RPS6—breast cancer	0.000133	0.000318	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGF4—breast cancer	0.000132	0.000316	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGF4—breast cancer	0.000132	0.000316	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—FGFR1—breast cancer	0.000132	0.000316	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CXCR4—breast cancer	0.000131	0.000315	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CXCL12—breast cancer	0.000131	0.000315	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CXCR4—breast cancer	0.000131	0.000315	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CXCL12—breast cancer	0.000131	0.000315	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ERBB3—breast cancer	0.000131	0.000313	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—FGFR2—breast cancer	0.00013	0.000313	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—VEGFA—breast cancer	0.00013	0.000312	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BCL2L1—breast cancer	0.00013	0.000312	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PAK1—breast cancer	0.000129	0.000309	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PAK1—breast cancer	0.000129	0.000309	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TCF7L2—breast cancer	0.000127	0.000303	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TCF7L2—breast cancer	0.000127	0.000303	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MTHFR—breast cancer	0.000126	0.000301	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TERT—breast cancer	0.000125	0.0003	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—MAPK3—breast cancer	0.000123	0.000295	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NOTCH2—breast cancer	0.000122	0.000293	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HSP90AA1—breast cancer	0.000122	0.000293	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HSP90AA1—breast cancer	0.000122	0.000293	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NOTCH2—breast cancer	0.000122	0.000293	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—FGFR1—breast cancer	0.000122	0.000291	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HIF1A—breast cancer	0.00012	0.000287	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TGFB1—breast cancer	0.00012	0.000287	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AGTR1—breast cancer	0.000119	0.000285	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PRL—breast cancer	0.000119	0.000285	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PRL—breast cancer	0.000119	0.000285	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AGTR1—breast cancer	0.000119	0.000285	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—NFKBIA—breast cancer	0.000118	0.000283	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—STK11—breast cancer	0.000117	0.00028	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ADAM10—breast cancer	0.000117	0.00028	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ADAM10—breast cancer	0.000117	0.00028	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—STK11—breast cancer	0.000117	0.00028	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CAV1—breast cancer	0.000116	0.000278	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PLG—breast cancer	0.000116	0.000277	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PLG—breast cancer	0.000116	0.000277	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—KIT—breast cancer	0.000114	0.000274	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGF10—breast cancer	0.000114	0.000273	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGF10—breast cancer	0.000114	0.000273	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EGF—breast cancer	0.000113	0.000271	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—KRAS—breast cancer	0.000111	0.000266	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PDGFA—breast cancer	0.00011	0.000263	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PDGFA—breast cancer	0.00011	0.000263	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—FOS—breast cancer	0.000109	0.000261	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NOS2—breast cancer	0.000109	0.000261	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TGFBR2—breast cancer	0.000108	0.00026	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TGFBR2—breast cancer	0.000108	0.00026	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NOTCH1—breast cancer	0.000108	0.000259	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ITPR1—breast cancer	0.000107	0.000255	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ITPR1—breast cancer	0.000107	0.000255	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CASP8—breast cancer	0.000106	0.000255	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MMP3—breast cancer	0.000106	0.000254	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—STAT5A—breast cancer	0.000106	0.000254	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ERBB4—breast cancer	0.000106	0.000254	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ERBB4—breast cancer	0.000106	0.000254	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—STAT5A—breast cancer	0.000106	0.000254	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MMP3—breast cancer	0.000106	0.000254	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APC—breast cancer	0.000106	0.000253	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—KIT—breast cancer	0.000106	0.000253	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDH1—breast cancer	0.000105	0.000252	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—AKT2—breast cancer	0.000105	0.000251	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EGF—breast cancer	0.000104	0.00025	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SMAD4—breast cancer	0.000103	0.000246	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SMAD4—breast cancer	0.000103	0.000246	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IGF1R—breast cancer	0.000102	0.000244	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IGF1R—breast cancer	0.000102	0.000244	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CA—breast cancer	0.000102	0.000244	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CD—breast cancer	0.0001	0.000241	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HES1—breast cancer	0.0001	0.00024	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HES1—breast cancer	0.0001	0.00024	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PLA2G4A—breast cancer	9.95e-05	0.000238	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NCOR1—breast cancer	9.95e-05	0.000238	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NCOR1—breast cancer	9.95e-05	0.000238	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PLA2G4A—breast cancer	9.95e-05	0.000238	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—BRAF—breast cancer	9.92e-05	0.000238	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TP53—breast cancer	9.85e-05	0.000236	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CSF2—breast cancer	9.84e-05	0.000236	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CSF2—breast cancer	9.84e-05	0.000236	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGF1—breast cancer	9.84e-05	0.000236	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGF1—breast cancer	9.84e-05	0.000236	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NRG1—breast cancer	9.77e-05	0.000234	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NRG1—breast cancer	9.77e-05	0.000234	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—H2AFX—breast cancer	9.7e-05	0.000232	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—H2AFX—breast cancer	9.7e-05	0.000232	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—AKT2—breast cancer	9.65e-05	0.000231	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—E2F1—breast cancer	9.63e-05	0.000231	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—E2F1—breast cancer	9.63e-05	0.000231	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—HRAS—breast cancer	9.42e-05	0.000226	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CD—breast cancer	9.28e-05	0.000222	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SPP1—breast cancer	9.25e-05	0.000222	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SPP1—breast cancer	9.25e-05	0.000222	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SERPINE1—breast cancer	9.17e-05	0.00022	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ERBB3—breast cancer	9.15e-05	0.000219	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ERBB3—breast cancer	9.15e-05	0.000219	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGFR2—breast cancer	9.14e-05	0.000219	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGFR2—breast cancer	9.14e-05	0.000219	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BCL2—breast cancer	9.13e-05	0.000219	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IFNG—breast cancer	9.05e-05	0.000217	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MDM2—breast cancer	9e-05	0.000216	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—RAF1—breast cancer	8.97e-05	0.000215	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—RELA—breast cancer	8.93e-05	0.000214	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ERBB2—breast cancer	8.87e-05	0.000213	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TERT—breast cancer	8.77e-05	0.00021	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TERT—breast cancer	8.77e-05	0.00021	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NOS3—breast cancer	8.76e-05	0.00021	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CB—breast cancer	8.76e-05	0.00021	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MTOR—breast cancer	8.76e-05	0.00021	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD4—breast cancer	8.74e-05	0.000209	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGFR1—breast cancer	8.52e-05	0.000204	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGFR1—breast cancer	8.52e-05	0.000204	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HIF1A—breast cancer	8.39e-05	0.000201	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HIF1A—breast cancer	8.39e-05	0.000201	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—AKT1—breast cancer	8.32e-05	0.000199	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MDM2—breast cancer	8.31e-05	0.000199	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—RAF1—breast cancer	8.28e-05	0.000198	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDKN1B—breast cancer	8.22e-05	0.000197	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ERBB2—breast cancer	8.19e-05	0.000196	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—LEP—breast cancer	8.19e-05	0.000196	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—LEP—breast cancer	8.19e-05	0.000196	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CAV1—breast cancer	8.11e-05	0.000194	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CAV1—breast cancer	8.11e-05	0.000194	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MTOR—breast cancer	8.08e-05	0.000194	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CB—breast cancer	8.08e-05	0.000194	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL1B—breast cancer	8.07e-05	0.000193	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CD4—breast cancer	8.07e-05	0.000193	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL2—breast cancer	8.04e-05	0.000193	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KDR—breast cancer	8.02e-05	0.000192	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KDR—breast cancer	8.02e-05	0.000192	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTGS2—breast cancer	8.01e-05	0.000192	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—JUN—breast cancer	7.82e-05	0.000187	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ESR1—breast cancer	7.82e-05	0.000187	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ESR1—breast cancer	7.82e-05	0.000187	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CTNNB1—breast cancer	7.76e-05	0.000186	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FN1—breast cancer	7.72e-05	0.000185	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FN1—breast cancer	7.72e-05	0.000185	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NFKBIA—breast cancer	7.63e-05	0.000183	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NFKBIA—breast cancer	7.63e-05	0.000183	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CDKN1B—breast cancer	7.59e-05	0.000182	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDKN1A—breast cancer	7.58e-05	0.000182	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PTEN—breast cancer	7.57e-05	0.000181	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NOTCH1—breast cancer	7.56e-05	0.000181	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NOTCH1—breast cancer	7.56e-05	0.000181	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAPK8—breast cancer	7.4e-05	0.000177	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APC—breast cancer	7.39e-05	0.000177	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KIT—breast cancer	7.39e-05	0.000177	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CG—breast cancer	7.39e-05	0.000177	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CG—breast cancer	7.39e-05	0.000177	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KIT—breast cancer	7.39e-05	0.000177	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APC—breast cancer	7.39e-05	0.000177	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EGF—breast cancer	7.3e-05	0.000175	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EGF—breast cancer	7.3e-05	0.000175	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CTNNB1—breast cancer	7.17e-05	0.000172	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—SRC—breast cancer	7.02e-05	0.000168	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CDKN1A—breast cancer	7e-05	0.000168	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTEN—breast cancer	6.99e-05	0.000167	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—BRAF—breast cancer	6.95e-05	0.000166	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—BRAF—breast cancer	6.95e-05	0.000166	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—STAT3—breast cancer	6.77e-05	0.000162	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IGF1—breast cancer	6.77e-05	0.000162	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IGF1—breast cancer	6.77e-05	0.000162	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AKT2—breast cancer	6.76e-05	0.000162	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AKT2—breast cancer	6.76e-05	0.000162	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CD—breast cancer	6.5e-05	0.000156	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CD—breast cancer	6.5e-05	0.000156	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SRC—breast cancer	6.48e-05	0.000155	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAPK3—breast cancer	6.47e-05	0.000155	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SERPINE1—breast cancer	6.42e-05	0.000154	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SERPINE1—breast cancer	6.42e-05	0.000154	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—STAT3—breast cancer	6.25e-05	0.00015	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EGFR—breast cancer	6.15e-05	0.000147	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NOS3—breast cancer	6.13e-05	0.000147	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NOS3—breast cancer	6.13e-05	0.000147	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MAPK3—breast cancer	5.97e-05	0.000143	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MDM2—breast cancer	5.82e-05	0.000139	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MDM2—breast cancer	5.82e-05	0.000139	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—KRAS—breast cancer	5.81e-05	0.000139	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MYC—breast cancer	5.81e-05	0.000139	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RAF1—breast cancer	5.8e-05	0.000139	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RAF1—breast cancer	5.8e-05	0.000139	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TGFB1—breast cancer	5.79e-05	0.000139	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RELA—breast cancer	5.77e-05	0.000138	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RELA—breast cancer	5.77e-05	0.000138	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ERBB2—breast cancer	5.74e-05	0.000137	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ERBB2—breast cancer	5.74e-05	0.000137	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EGFR—breast cancer	5.68e-05	0.000136	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CB—breast cancer	5.66e-05	0.000136	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MTOR—breast cancer	5.66e-05	0.000136	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MTOR—breast cancer	5.66e-05	0.000136	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CB—breast cancer	5.66e-05	0.000136	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CXCL8—breast cancer	5.44e-05	0.00013	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CXCL8—breast cancer	5.44e-05	0.00013	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—KRAS—breast cancer	5.36e-05	0.000129	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CA—breast cancer	5.34e-05	0.000128	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CDKN1B—breast cancer	5.31e-05	0.000127	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDKN1B—breast cancer	5.31e-05	0.000127	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CASP3—breast cancer	5.21e-05	0.000125	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CASP3—breast cancer	5.21e-05	0.000125	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL2—breast cancer	5.2e-05	0.000125	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL2—breast cancer	5.2e-05	0.000125	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCND1—breast cancer	5.07e-05	0.000121	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCND1—breast cancer	5.07e-05	0.000121	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—JUN—breast cancer	5.06e-05	0.000121	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—JUN—breast cancer	5.06e-05	0.000121	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CTNNB1—breast cancer	5.02e-05	0.00012	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CTNNB1—breast cancer	5.02e-05	0.00012	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HRAS—breast cancer	4.94e-05	0.000118	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CA—breast cancer	4.93e-05	0.000118	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MMP9—breast cancer	4.92e-05	0.000118	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MMP9—breast cancer	4.92e-05	0.000118	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CDKN1A—breast cancer	4.9e-05	0.000118	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDKN1A—breast cancer	4.9e-05	0.000118	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PTEN—breast cancer	4.89e-05	0.000117	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PTEN—breast cancer	4.89e-05	0.000117	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAPK8—breast cancer	4.79e-05	0.000115	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAPK8—breast cancer	4.79e-05	0.000115	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL6—breast cancer	4.73e-05	0.000113	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HRAS—breast cancer	4.56e-05	0.000109	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SRC—breast cancer	4.54e-05	0.000109	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SRC—breast cancer	4.54e-05	0.000109	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VEGFA—breast cancer	4.42e-05	0.000106	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VEGFA—breast cancer	4.42e-05	0.000106	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—STAT3—breast cancer	4.38e-05	0.000105	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—STAT3—breast cancer	4.38e-05	0.000105	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IL6—breast cancer	4.36e-05	0.000105	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—AKT1—breast cancer	4.36e-05	0.000105	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAPK3—breast cancer	4.18e-05	0.0001	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAPK3—breast cancer	4.18e-05	0.0001	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MYC—breast cancer	4.07e-05	9.74e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MYC—breast cancer	4.07e-05	9.74e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TGFB1—breast cancer	4.06e-05	9.72e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TGFB1—breast cancer	4.06e-05	9.72e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—AKT1—breast cancer	4.03e-05	9.65e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EGFR—breast cancer	3.98e-05	9.53e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EGFR—breast cancer	3.98e-05	9.53e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KRAS—breast cancer	3.76e-05	9e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KRAS—breast cancer	3.76e-05	9e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CA—breast cancer	3.45e-05	8.27e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CA—breast cancer	3.45e-05	8.27e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TP53—breast cancer	3.34e-05	8e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TP53—breast cancer	3.34e-05	8e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HRAS—breast cancer	3.19e-05	7.65e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HRAS—breast cancer	3.19e-05	7.65e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL6—breast cancer	3.06e-05	7.32e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL6—breast cancer	3.06e-05	7.32e-05	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AKT1—breast cancer	2.82e-05	6.76e-05	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AKT1—breast cancer	2.82e-05	6.76e-05	CbGpPWpGaD
